首页> 外文期刊>Journal of Medicinal Chemistry >Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Substite at C1'
【24h】

Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Substite at C1'

机译:大麻素侧链的药理要求。在C1'探测大麻素受体替代物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Earlier work from our laboratories has provided evidence for the existence of a subsite within the CB1 and CB2 cannabinoid receptor binding domain corresponding to substituents at the benzylic side chain position of classical cannabinoids. The existence and stereochemical features of this subsite have now been probed through the synthesis of a novel series of (-)-△~8-tetrahydrocannabinol analogues bearing C1'-ring substituents. Of the compounds described here, those with C1'-dithiolane (1c), C1'-dioxolane (2d), and cyclopentyl (2a) substituents exhibited the highest affinities for CB1 and CB2. We used molecular modeling approaches to better define the stereochemical limits of the putative subsite. In vitro pharmacological testing found 1c to be a potent CB1 agonist.
机译:我们实验室的早期工作为CB1和CB2大麻素受体结合域内存在一个亚位点提供了证据,该位点对应于经典大麻素苄基侧链位置的取代基。现在已经通过合成一系列带有C1'-环取代基的(-)-△〜8-四氢大麻酚类似物来探索该亚位点的存在和立体化学特征。在本文所述的化合物中,具有C1'-二硫杂环戊烷(1c),C1'-二氧戊环(2d)和环戊基(2a)取代基的化合物表现出对CB1和CB2的最高亲和力。我们使用分子建模方法更好地定义了假定亚位点的立体化学极限。体外药理测试发现1c是有效的CB1激动剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号